Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06895382Completed
Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Tekirdağ Namık Kemal University. Primary endpoint: Postoperative FLACC Pain Scores at 24 hours. Started Dec 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06895382.